Format

Send to

Choose Destination
Ann Oncol. 2015 Oct;26(10):2102-6. doi: 10.1093/annonc/mdv331. Epub 2015 Jul 30.

Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer.

Author information

1
Faculty of Medicine, University of Ottawa, Ottawa.
2
Department of Oncology, Tom Baker Cancer Centre, Calgary.
3
Department of Oncology, Dr. H. Bliss Murphy Cancer Centre, St. John's.
4
Division of Medical Oncology, The Ottawa Hospital, Ottawa.
5
Department of Surgery, University of Calgary, Calgary.
6
Department of Oncology, Cross Cancer Institute, Edmonton.
7
Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada.
8
Division of Medical Oncology, The Ottawa Hospital, Ottawa mvickers@toh.on.ca.

Abstract

BACKGROUND:

Studies of clinical outcomes of elderly patients treated with neoadjuvant chemoradiation (nCRT) for locally advanced rectal cancer (LARC) are limited. Our aim was to assess the impact of age on clinical outcomes in a large multi-institutional database.

PATIENTS AND METHODS:

Data for patients diagnosed with LARC who received nCRT and curative-intent surgery between 2005 and 2012 were collected from five major Canadian cancer centers. Age was analyzed as a continuous and dichotomous variable (< 70 versus ≥ 70 years) and correlated with disease-free survival (DFS), cancer-specific survival (CSS) and overall survival (OS). Cox regression models were used to adjust for important prognostic factors.

RESULTS:

Of 1172 patients included, 295 (25%) were ≥ 70 years, and they were less likely to receive adjuvant chemotherapy (ACT; 60% versus 79%, P < 0.0001), oxaliplatin-based ACT (12% versus 31%, P < 0.0001), less likely to complete nCT (76% versus 86%, P < 0.001), and more likely to be anemic at initiation of nCRT (42% versus 30%, P = 0.0004). In multivariate analyses, age ≥ 70 years was associated with similar DFS [hazard ratio (HR) 0.93, 95% confidence interval (CI) 0.68-1.26, P = 0.63], similar CSS (HR 0.81, 95% CI 0.46-1.41, P = 0.45), and similar OS (HR 1.28, 95% CI 0.88-1.86, P = 0.20), compared with the younger age group. As a continuous variable, increasing age was not predictive of DFS (HR 1.00, 95% CI 0.99-1.02, P = 0.49) or CSS (HR 1.002, 95% CI 0.98-1.02, P = 0.88); however, it correlated with an inferior OS (HR 1.02, 95% CI 1.00-1.03, P = 0.04).

CONCLUSIONS:

Elderly patients (≥ 70 years) who receive nCRT followed by surgery appear to have similar outcomes compared with younger patients. Decisions regarding eligibility for nCRT and surgery should not be based on age alone.

KEYWORDS:

elderly patients; neoadjuvant chemoradiation; rectal cancer; survival

PMID:
26232491
DOI:
10.1093/annonc/mdv331
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center